Investment Firm Upgrades Affy Stock Despite Disappointing Q1 Results

Apr 24, 2006

NEW YORK, April 24 (GenomeWeb News) - Investment firm Global Brown Capital upgraded Affymetrix's stock to "Overweight" from "Underweight" today despite the microarray company's disappointing first-quarter revenue and earnings, announced late last week.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Marine Mammal Gene Loss

National Geographic reports that marine mammals have lost a gene that could make them more susceptible to organophosphate damage.

Cell Count

NPR reports on Human Cell Atlas Consortium's effort to catalog all the different cell types within the human body.

Varied Opinions

The Union of Concerned Scientists surveyed US government scientists about Trump Administration policies and more, Science reports.

This Week in PNAS

In PNAS this week: history and genetic diversity of the scarlet macaw, approach for predicting human flu virus evolution, and more.

Main menu